MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BRVE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Braveheart Bio (BRVE) Ownership - Who owns Braveheart Bio?

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
One Letterman Drive
Phone
+1 415 707-6312
Employees
30
Web
https://www.braveheart.bio

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.63B
P/E Ratio
N/A
Total Cash
122.83M
Projected Growth
N/A
Total Debt
575K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for BRVE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Letterman Drive
Phone
+1 415 707-6312
Employees
30
Web
https://www.braveheart.bio
Who owns Braveheart Bio? BRVE symbol Ownership - Tickeron.com